Suggested risk factor for oral lichen planus arising after mRNA COVID-19 vaccination

Massoumeh Zargaran

doi:10.1002/ccr3.6126

Suggested risk factor for oral lichen planus arising after mRNA COVID-19 vaccination

Clin Case Rep. 2022 Jul 22;10(7):e6126. doi: 10.1002/ccr3.6126. eCollection 2022 Jul.

Author

Massoumeh Zargaran¹

Affiliation

¹ Department of Oral and Maxillofacial Pathology, Faculty of Dentistry Kurdistan University of Medical Sciences Sanandaj Iran.

Abstract

A single dose of BNT162b2 vaccine is suggested for COVID-19-infected individuals to reduce side effects due to release of inflammatory mediators such as oral lichen planus (OLP).

Publication types

Editorial